Tisagenlecleucel,Axicabtagene ciloleucel
Novartis,gilead,daiichi sankyo
['axi-cel', 'lymsm']
while the orr of axi-cel is great in the elderly, 5/40 mortality due to infection make this a questionable approach given the presence of many alternatives #lymsm #eha2023 #eha23 
An associate member @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.